Schouw & Co (SCHO) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
12 Nov, 2025Executive summary
Q3 2025 saw a 4% revenue decline to DKK 9.2 billion, but EBITDA rose 5% to DKK 878 million, supported by strong pricing, cost control, and diversified business performance amid challenging markets.
HydraSpecma and Fibertex Personal Care outperformed, while BioMar Norway and Borg Automotive faced environmental and market headwinds.
Strategic restructuring and footprint optimization incurred nearly DKK 100 million in one-off costs, impacting EBITDA.
Cash flow remained robust at DKK 894 million, with improved net interest-bearing debt and leverage.
Preparation for a potential BioMar IPO is progressing, with a possible listing in H1 2026.
Financial highlights
Q3 2025 revenue was DKK 9,195 million, down 4% year-over-year; EBITDA rose 5% to DKK 878 million.
Cash flow from operations in Q3 was DKK 894 million; net interest-bearing debt decreased by DKK 519 million in Q3.
Full-year 2025 revenue guidance narrowed to DKK 33.7–34.7 billion; EBITDA guidance to DKK 2,850–3,020 million, including over DKK 90 million in one-off costs.
Q3 profit before tax increased 7% to DKK 522 million; earnings per share for Q3 was DKK 15.53, up 6% year-over-year.
Investments remained modest, with Q3 investment at DKK 104 million.
Outlook and guidance
Full-year 2025 revenue and EBITDA guidance narrowed, reflecting market headwinds and restructuring impacts.
BioMar, GPV, and Fibertex Nonwovens narrowed guidance; HydraSpecma and Fibertex Personal Care raised EBITDA outlooks.
Borg Automotive lowered both revenue and EBITDA guidance due to persistent market challenges.
BioMar: FY turnover expected at DKK 16.3–16.7 billion, EBITDA DKK 1.49–1.53 billion.
GPV: FY revenue DKK 8.7–8.9 billion, EBITDA DKK 620–650 million (including DKK 10–15 million one-offs in Q4).
HydraSpecma: FY revenue DKK 3.1–3.2 billion, EBITDA DKK 380–400 million.
Borg Automotive: FY revenue DKK 1.8–1.9 billion, EBITDA DKK 60–80 million (including DKK 40 million one-offs).
Fibertex Personal Care: FY revenue DKK 1.6–1.7 billion, EBITDA DKK 180–200 million.
Fibertex Nonwovens: FY revenue DKK 2.2–2.3 billion, EBITDA DKK 200–220 million.
Latest events from Schouw & Co
- Record cash flow and EBITDA growth in most segments, with improved leverage and strong 2026 outlook.SCHO
Q4 20255 Mar 2026 - EBITDA guidance raised as margin gains offset revenue decline amid market headwinds.SCHO
Q2 20241 Feb 2026 - Revenue and EBITDA fell, but margins and cash flow held; BioMar IPO and cost cuts in focus.SCHO
Q3 202415 Jan 2026 - EBITDA rose 3% to DKK 2.93bn despite a 7% revenue drop, with strong cash flow and lower debt.SCHO
Q4 202423 Dec 2025 - Q1 2025 revenue up 1%, EBITDA down 13%, guidance maintained, BioMar IPO prep advances.SCHO
Q1 202529 Nov 2025 - Stable Q2 with strong cash flow and narrowed guidance; segment outlooks mixed amid volatility.SCHO
Q2 202523 Nov 2025